STK38L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.507000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.580360E-01
Normal-vs-Stage2
4.198400E-01
Normal-vs-Stage3
3.962600E-01
Normal-vs-Stage4
4.440200E-01
Stage1-vs-Stage2
1.452420E-01
Stage1-vs-Stage3
6.329200E-01
Stage1-vs-Stage4
1.777810E-01
Stage2-vs-Stage3
4.773000E-01
Stage2-vs-Stage4
2.626200E-01
Stage3-vs-Stage4
1.727200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.395800E-01
Normal-vs-AfricanAmerican
3.535400E-01
Normal-vs-Asian
5.893400E-01
Caucasian-vs-AfricanAmerican
7.316200E-01
Caucasian-vs-Asian
7.091600E-01
AfricanAmerican-vs-Asian
5.170600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.045800E-01
Normal-vs-Female
5.318800E-01
Male-vs-Female
4.770200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.334400E-01
Normal-vs-Age(41-60Yrs)
6.762800E-01
Normal-vs-Age(61-80Yrs)
3.940000E-01
Normal-vs-Age(81-100Yrs)
1.565980E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.388200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.213200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.811000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.555200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.627900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.951400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.514600E-01
Normal-vs-Daily Drinker
1.229410E-01
Normal-vs-Weekly Drinker
4.572000E-01
Normal-vs-Occasional Drinker
9.315000E-01
Normal-vs-Social Drinker
4.270600E-01
Non Drinker-vs-Daily Drinker
2.558000E-01
Non Drinker-vs-Weekly Drinker
7.382400E-01
Non Drinker-vs-Occasional Drinker
1.641050E-01
Non Drinker-vs-Social Drinker
9.402400E-01
Daily Drinker-vs-Weekly Drinker
1.775840E-01
Daily Drinker-vs-Occasional Drinker
4.893900E-02
Daily Drinker-vs-Social Drinker
2.991400E-01
Weekly Drinker-vs-Occasional Drinker
3.781400E-01
Weekly Drinker-vs-Social Drinker
8.242600E-01
Occasional Drinker-vs-Social Drinker
2.941200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.093400E-01
Normal-vs-Grade 2
2.423600E-02
Normal-vs-Grade 3
9.604200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.585600E-02
Grade 1-vs-Grade 3
4.516300E-02
Grade 1-vs-Grade 4
1.093400E-01
Grade 2-vs-Grade 3
5.229800E-01
Grade 2-vs-Grade 4
2.423600E-02
Grade 3-vs-Grade 4
9.604200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.684000E-01
Normal-vs-NonDiabetic
4.095600E-01
Diabetic-vs-NonDiabetic
7.924200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.529800E-01
Normal-vs-NoPancreatitis
4.373200E-01
Pancreatitis-vs-NoPancreatitis
3.276000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.709800E-01
Normal-vs-N1
4.678400E-01
N0-vs-N1
4.700000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.792200E-01
Normal-vs-TP53-NonMutant
1.773040E-01
TP53-Mutant-vs-TP53-NonMutant
1.396380E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
